Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key
- PMID: 24159006
- DOI: 10.1177/0145721713508822
Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key
Abstract
This review provides information to equip diabetes educators to instruct and guide patients in using U-500 human regular insulin (U-500R). The article includes an overview of U-500R pharmacology and clinical data, strategies for outpatient and inpatient use, and tools for patient education. U-500R is useful for treating patients with any type of diabetes who require high doses of insulin. U-500R alleviates the volume-related problems associated with high doses of U-100 insulin, making treatment with high doses of insulin more feasible (because of the need for fewer injections for patients) as well as more cost-efficient and potentially more effective. These tools can help diabetes educators feel more comfortable and confident as they advise and educate patients who receive high-dose U-500R as part of their overall diabetes care plan. The diabetes educator plays a vital role in helping patients use U-500R safely and successfully.
Similar articles
-
Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach.Diabetes Educ. 2017 Jun;43(3):311-323. doi: 10.1177/0145721717701579. Epub 2017 Apr 21. Diabetes Educ. 2017. PMID: 28427304 Free PMC article.
-
Clinical use of U-500 regular insulin: review and meta-analysis.J Diabetes Sci Technol. 2012 Mar 1;6(2):412-20. doi: 10.1177/193229681200600229. J Diabetes Sci Technol. 2012. PMID: 22538155 Free PMC article. Review.
-
Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects.Diabetes Care. 2011 Dec;34(12):2496-501. doi: 10.2337/dc11-0721. Epub 2011 Oct 12. Diabetes Care. 2011. PMID: 21994429 Free PMC article. Clinical Trial.
-
TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIAL.Endocr Pract. 2015 Jul;21(7):782-93. doi: 10.4158/EP15612.OR. Epub 2015 Mar 26. Endocr Pract. 2015. PMID: 25813411 Clinical Trial.
-
[Clinical aspects of Insulin Lispro (LY275585)].Nihon Rinsho. 1997 Nov;55 Suppl:298-305. Nihon Rinsho. 1997. PMID: 9434484 Review. Japanese. No abstract available.
Cited by
-
Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance.Medicine (Baltimore). 2015 Jul;94(30):e1160. doi: 10.1097/MD.0000000000001160. Medicine (Baltimore). 2015. PMID: 26222846 Free PMC article. Clinical Trial.
-
Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes Mellitus.J Manag Care Spec Pharm. 2020 Jul;26(7):839-847. doi: 10.18553/jmcp.2020.26.7.839. J Manag Care Spec Pharm. 2020. PMID: 32584684 Free PMC article.
-
Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach.Diabetes Educ. 2017 Jun;43(3):311-323. doi: 10.1177/0145721717701579. Epub 2017 Apr 21. Diabetes Educ. 2017. PMID: 28427304 Free PMC article.
-
Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study.BMJ Open Diabetes Res Care. 2015 Apr 30;3(1):e000074. doi: 10.1136/bmjdrc-2014-000074. eCollection 2015. BMJ Open Diabetes Res Care. 2015. PMID: 25969741 Free PMC article.
-
Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes.Diabetes Care. 2023 Apr 1;46(4):757-764. doi: 10.2337/dc22-1054. Diabetes Care. 2023. PMID: 36710473 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical